A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

Diabetes

Volumn 52, Issue 7, 2003, Pages 1611-1618

  Smith, Steve R ^a   Bai, Fulu ^b   Charbonneau, Chantal ^b   Janderová, Lenka ^b   Argyropoulos, George ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); RESISTIN;

ADIPOCYTE; ADULT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; FEMALE; GENOTYPE; HEREDITY; HOMEOSTASIS; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN RESISTANCE; LIVER; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OXIDATIVE STRESS; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBCUTANEOUS FAT; X RAY ANALYSIS;

EID: 0038692862     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.7.1611     Document Type: Article

References (41)

1. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hebert CC: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055, 2000
2. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001
3. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, Hotamisligil GS: Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276:25651-25653, 2001
4. Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, Di Mario U, Baroni MG: Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 51:860-862, 2002
5. Osawa H, Onuma H, Murakami A, Ochi M, Nishimiya T, Kato K, Shimizu I, Fujii Y, Ohashi J, Makino H: Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 51:863-866, 2002
6. Wang H, Chu WS, Hemphill C, Elbein SC: Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:2520-2524, 2002
7. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S: Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50: 2199-2202, 2001
8. Nagaev I, Smith U: Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561-564, 2001
9. Lay SL, Boucher J, Rey A, Castan-Laurell I, Krief S, Ferre P, Valet P, Dugail I: Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 289:564-567, 2001
10. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM: Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 10:1-5, 2002
11. Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, Barzilai N, Scherer PE: Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 16:1920-1930, 2002
12. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S: Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47, 2002
13. Ghosh S, Singh AK, Aruna B, Mukhopadhyay S, Ehtesham NZ: The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 305:27-34, 2003
14. Kim KH, Lee K, Moon YS, Sul HS: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256, 2001
15. Danforth E Jr: Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13, 2000
16. Unger RH, Orci L: Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 24 (Suppl. 4):S28-S32, 2000
17. Raha S, Myint AT, Johnstone L, Robinson BH: Control of oxygen free radical formation from mitochondrial complex I: roles for protein kinase A and pyruvate dehydrogenase kinase. Free Radic Biol Med 32:421-430, 2002
18. Morin N, Lizcano J-M, Fontana E, Marti L, Smih F, Rouet P, Prevot D, Zorzano A, Unzeta M, Carpene C: Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. J Pharmacol Exp Ther 297:563-572, 2001
19. Kern PA, Fishman RB, Song W, Brown AD, Fonseca V: The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on oxidative enzymes in adipocytes and liver. Toxicology 171:117-125, 2002
20. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y: Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82-83:173-179, 1995
21. Jaiswal AK: Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic Biol Med 29:254-262, 2000
22. Gaikwad A, Long DJ 2nd, Stringer JL, Jaiswal AK: In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J Biol Chem 276:22559-22564, 2001
23. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52:1-8, 2003
24. Rudich A, Kozlovsky N, Potashnik R, Bashan N: Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol 272:E935-E940, 1997
25. Rudich A, Tirosh A, Potashnik R, Khamaisi M, Bashan N: Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 42:949-957, 1999
26. Tirosh A, Rudich A, Potashnik R, Bashan N: Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes. Biochem J 355:757-763, 2001
27. Evans JL, Goldfine ID: Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2:401-413, 2000
28. Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA: Mechanisms regulating adipocyte expression of resistin. J Biol Chem 277:19764-19761, 2002
29. Schug J, Overton C: TESS: transcription element search software on the WWW, technical report CBIL-TR-1997-1001-v0.0. Pittsburgh, PA, Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania, 1997. Available from www.cbil.upenn.edu/tess
30. Mayfield DK, Brown AM, Page GP, Garvey WT, Shriver MD, Argyropoulos G: A role for the agouti related protein promoter in obesity and type 2 diabetes. Biochem Biophys Res Commun 287:568-573, 2001
31. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA: Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 50:425-435, 2001
32. Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Jarvinen H: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749-758, 2000
33. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
34. Weintraub H, Davis R, Lockshon D, Lassar A: MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc Natl Acad Sci U S A 87:5623-5627, 1990
35. Engert JC, Vohl MC, Williams SM, Lepage P, Loredo-Osti JC, Faith J, Dore C, Renaud Y, Burtt NP, Villeneuve A, Hirschhorn JN, Altshuler D, Groop LC, Despres JP, Gaudet D, Hudson TJ: 5′ flanking variants of resistin are associated with obesity. Diabetes 51:1629-1634, 2002
36. Pizzuti A, Argiolas A, Di Paola R, Baratta R, Rauseo A, Bozzali M, Vigneri R, Dallapiccola B, Trischitta V, Frittitta L: An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 87:4403-4406, 2002
37. Ma X, Warram JH, Trischitta V, Doria A: Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:4407-4410, 2002
38. Ammendola R, Mesuraca M, Russo T, Cimino F: The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 225:483-489, 1994
39. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226, 2000
40. Steppan CM, Lazar MA: Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23, 2002
41. Smith SR, Ravussin E: Emerging paradigms for understanding fatness and diabetes risk. Curr Diab Rep 2:223-230, 2002